Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Spruce Capital Partners, LLC is a venture capital firm located in San Francisco, specializing in life sciences investments. The firm collaborates with experienced Managing Partners who have over a decade of experience in investing and advising within the sector. They co-manage the MLS Capital Fund II, focusing on innovative solutions in health and wellness.
Spruce Capital Partners invests in seed to Series B life sciences companies, particularly those addressing health and environmental issues. Their portfolio includes biotech, healthcare, and agtech sectors, with a commitment to supporting innovations that improve health and wellness. Typical check sizes are not disclosed, but the firm emphasizes impactful solutions.
Notable companies in Spruce Capital Partners' portfolio include AGERpoint, which develops 3D modeling tools for agriculture; Amfora, focusing on nutritionally-enhanced crops; and Consumer Physics, known for its pocket-sized spectrometer. Other investments include Crop Enhancement, Evolve, GreenLight, Inscripta, Pivot Bio, and Provivi.
Submit your pitch through their form at https://www.sprucecp.com/contact or email your deck to info@sprucecp.com.
Yes, Spruce Capital Partners often leads investment rounds in their portfolio companies, particularly in the early stages of development.
The firm is open to follow-on investments, especially for companies that demonstrate significant progress and alignment with their investment thesis.
Specific fund size details are not publicly available, but they co-manage the MLS Capital Fund II, which supports various investments in life sciences.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.